Scientists have just discovered a new mechanism by which HIV evades the immune system, and which shows precisely how the virus avoids elimination. The new research shows that HIV targets and disables a pathway involving a number of biological molecules that are key in blocking viral activity and clearing infection.
HIV remains a major global health problem, with more than 40 million people infected worldwide. And while people living with HIV have been treated with antiretroviral therapy for over 30 years, this favored therapeutic option merely prevents the progression of the disease to AIDS - it doesn't cure patients of HIV.
The discovery, which opens the door to a new era of HIV research focused on curing people living with the virus, has just been published in international journal, EBioMedicine, which is a collaborative online journal from Cell Press and the Lancet.
During any viral infection our immune system produces a powerful molecule (Interferon), which 'interferes' with the infection and the replication of viruses. Interferon activates an assembly line of molecules in our cells -- via the Interferon signalling pathway - which causes the body to make antivirals that help to clear the infection.
However, when patients are being treated with antiretroviral therapy, HIV is not fully cleared by our immune system. Therefore, the scientists from Trinity College Dublin behind the research investigated whether HIV was somehow blocking the Interferon signalling pathway and thus avoiding the immune response that is designed to cure viral infection. The findings confirmed their suspicions.
Nigel Stevenson, assistant professor in immunology at Trinity, led the work. He said, "We discovered that HIV promotes the destruction of the anti-viral Interferon signalling pathway. Essentially, HIV uses the machinery in our own cells to do this, and the virus is thus able to reduce the production of many important anti-viral molecules. Without these antiviral molecules, our immune system can't clear viral infections. Our new revelation sheds new light on how HIV avoids elimination, which, in turn, may explain why HIV is still not a curable disease. We feel this discovery could mark a paradigm shift in our understanding of how this virus evades our immune response. It should open the door to a new era of HIV research aiming to cure and eradicate this deadly virus."
Source: Trinity College Dublin
CDC Urges Vigilance: New Recommendations for Monitoring and Testing H5N1 Exposures
July 11th 2025With avian influenza A(H5N1) infections surfacing in both animals and humans, the CDC has issued updated guidance calling for aggressive monitoring and targeted testing to contain the virus and protect public health.
IP LifeLine: Layoffs and the Evolving Job Market Landscape for Infection Preventionists
July 11th 2025Infection preventionists, once hailed as indispensable during the pandemic, now face a sobering reality: budget pressures, hiring freezes, and layoffs are reshaping the field, leaving many IPs worried about their future and questioning their value within health care organizations.
A Helping Hand: Innovative Approaches to Expanding Hand Hygiene Programs in Acute Care Settings
July 9th 2025Who knew candy, UV lights, and a college kid in scrubs could double hand hygiene adherence? A Pennsylvania hospital’s creative shake-up of its infection prevention program shows that sometimes it takes more than soap to get hands clean—and keep them that way.